53
Views
17
CrossRef citations to date
0
Altmetric
Original Research

SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma

, , &
Pages 1071-1079 | Published online: 21 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Peng Ge, Lei Cao, Yue-Juan Yao, Rui-Jun Jing, Wei Wang & Han-Jie Li. (2019) lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p–SIX1 axis. OncoTargets and Therapy 12, pages 6105-6117.
Read now
Liang Wang, Ming Wang, Mingyun Zhang, Xingde Li, Zhongcheng Zhu & Haiyan Wang. (2018) Expression and significance of RRBP1 in esophageal carcinoma. Cancer Management and Research 10, pages 1243-1249.
Read now

Articles from other publishers (15)

Samantha Hardy, Yeun-Mun Choo, Mark Hamann & James Cray. (2022) Manzamine-A Alters In Vitro Calvarial Osteoblast Function. Marine Drugs 20:10, pages 647.
Crossref
Hongyan Zhan, Hongxia Chen, Zizheng Tang, Shasha Liu, Kangqi Xie & Hui Wang. (2022) SIX1 attenuates inflammation and rheumatoid arthritis by silencing MyD88-dependent TLR1/2 signaling. International Immunopharmacology 106, pages 108613.
Crossref
Yu-Cheng Lee, Cheng-Han Lin, Wei-Lun Chang, Wen-Der Lin, Jhih-Kai Pan, Wei-Jan Wang, Bor-Chyuan Su, Hsien-Hui Chung, Chen-Hsun Tsai, Forn-Chia Lin, Wen-Ching Wang & Pei-Jung Lu. (2022) Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma. International Journal of Molecular Sciences 23:8, pages 4367.
Crossref
Qian Luo, Ruijuan Du, Wenting Liu, Guojing Huang, Zigang Dong & Xiang Li. (2022) PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy. Frontiers in Oncology 12.
Crossref
Guang Zhu, Ying Liu, Lei Zhao, Zhenhua Lin & Yingshi Piao. (2021) The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Oncology 11.
Crossref
Zhen Cui, Jia Liu, Qiaoyu Sun, Zelai He, Chaoge Wang, Xianwen Zhang, Qianqian Ma, Duojie Li & Hao Jiang. (2020) GPR120 promotes radiation resistance in esophageal cancer via regulating AKT and apoptosis pathway. Anti-Cancer Drugs 32:1, pages 53-60.
Crossref
Cong‐Cong Wu, Hao Li, Yao Xiao, Wei‐Wei Deng & Zhi‐Jun Sun. (2020) Expression levels of SIX1, ME2, and AP2M1 in adenoid cystic carcinoma and mucoepidermoid carcinoma. Oral Diseases 26:8, pages 1687-1695.
Crossref
Guangyong Chen, Zhuo Chen & Hang Zhao. (2020) MicroRNA‐155‐3p promotes glioma progression and temozolomide resistance by targeting Six1. Journal of Cellular and Molecular Medicine 24:9, pages 5363-5374.
Crossref
Hong‑Lin Li, Jun‑Jie Sun, Hui Ma, Shen‑Jia Liu, Na Li, Su‑Jie Guo, Yang Shi, Yan‑Ying Xu, Zhi‑Ying Qi, Yu‑Quan Wang, Fang Wang, Rui‑Meng Guo, Dong Liu & Feng‑Xia Xue. (2019) MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1. Oncology Letters.
Crossref
Zi-Yuan Nie, Xiao-Jun Liu, Ying Zhan, Meng-Han Liu, Xiao-Yan Zhang, Zi-Ye Li, Ya-Qiong Lu, Jian-Min Luo & Lin Yang. (2019) miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1. Bioscience Reports 39:4.
Crossref
Jin'e Wan, Jian Yang, Cuixia Qiao, Xiaomei Sun, Aiting Di, Lize Zhang, Dandan Wang & Gang Zhao. (2019) MicroRNA-362 Inhibits Cell Proliferation and Invasion by Directly Targeting SIX1 in Colorectal Cancer. Yonsei Medical Journal 60:5, pages 414.
Crossref
Tami J. Kingsbury, MinJung Kim & Curt I. Civin. 2019. Cancer Stem Cells. Cancer Stem Cells 1 42 .
Ying Liu, Yanping Tang & Ping Li. (2018) Inhibitory effect of microRNA‑455‑5p on biological functions of esophageal squamous cell carcinoma Eca109 cells via Rab31. Experimental and Therapeutic Medicine.
Crossref
Ruiqing ChenZeng WangRuilong LanFei HuangJinrong ChenYuanteng XuHengshan ZhangLurong Zhang. (2018) Influence of POLG on Radiosensitivity of Nasopharyngeal Carcinoma Cells . Cancer Biotherapy and Radiopharmaceuticals 33:4, pages 146-154.
Crossref
Zhuo Yang, ZiYi Feng, JiaHui Gu, XinHui Li, QianZhe Dong, KuiRan Liu, Yan Li & Ling OuYang. (2017) microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function. Oncotarget 8:46, pages 80981-80993.
Crossref